And so what this executive order yesterday does is address this problem in three different ways. The top line here is we're creating a strategic advanced Pharmaceutical Ingredient Reserve, number one. Number two, We are trying to stabilize long term demand through long term contracts from the government. which is the biggest buyer of pharmaceuticals. And three, a la the broader issue of regulatory reform, we are going to make it much easier for advanced manufacturing, continuous manufacturing to occur here and make us competitive. (00:58–01:08)
CLAIM
Asserts that the government will use long-term contracts to stabilize pharmaceutical demand.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
